Disclosures for "Serum Glucose Fluctuations Is an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment"
-
-
Dr. Chaudhry has nothing to disclose.
-
Dr. Khan has nothing to disclose.
-
Mr. Ali has nothing to disclose.
-
-
Dr. Chaudhry has nothing to disclose.
-
Dr. Khan has nothing to disclose.
-
Dr. Zaki has nothing to disclose.
-
-
Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.